CA
INSP icon

Cliff Asness’s Inspire Medical Systems INSP Stock Holding History

Cliff Asness’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.9M Buy
1,856,800
+1,548,138
+502% +$73.4M 0.03% 669
2026
Q1 		$15.9M Buy
308,662
+281,622
+1,042% +$19.7M 0.01% 1118
2025
Q4 		$2.49M Sell
27,040
-22,377
-45% -$2.14M ﹤0.01% 1999
2025
Q3 		$3.67M Sell
49,417
-71,993
-59% -$7.29M ﹤0.01% 1633
2025
Q2 		$15.8M Sell
121,410
-120,793
-50% -$17.5M 0.01% 843
2025
Q1 		$37.1M Sell
242,203
-196,641
-45% -$35.6M 0.04% 546
2024
Q4 		$81.4M Sell
438,844
-7,567
-2% -$1.47M 0.1% 256
2024
Q3 		$93.4M Buy
446,411
+214,566
+93% +$37.3M 0.13% 206
2024
Q2 		$31M Buy
231,845
+140,090
+153% +$26.5M 0.05% 449
2024
Q1 		$19.7M Buy
91,755
+28,312
+45% +$5.55M 0.03% 530
2023
Q4 		$12.9M Buy
63,443
+49,096
+342% +$7.95M 0.02% 615
2023
Q3 		$2.85M Buy
14,347
+8,538
+147% +$2.15M 0.01% 1164
2023
Q2 		$1.89M Sell
5,809
-2,633
-31% -$752K ﹤0.01% 1286
2023
Q1 		$1.98M Buy
8,442
+745
+10% +$188K ﹤0.01% 1262
2022
Q4 		$1.94M Sell
7,697
-3,825
-33% -$816K ﹤0.01% 1265
2022
Q3 		$2.04M Buy
11,522
+3,426
+42% +$688K 0.01% 1195
2022
Q2 		$1.48M Sell
8,096
-2,041
-20% -$407K ﹤0.01% 1251
2022
Q1 		$2.6M Sell
10,137
-5,797
-36% -$1.32M ﹤0.01% 1057
2021
Q4 		$3.67M Buy
15,934
+1,254
+9% +$306K 0.01% 911
2021
Q3 		$3.42M Buy
14,680
+148
+1% +$30.9K 0.01% 915
2021
Q2 		$2.81M Buy
14,532
+1,225
+9% +$243K ﹤0.01% 1046
2021
Q1 		$2.75M Buy
13,307
+1,229
+10% +$261K ﹤0.01% 1040
2020
Q4 		$2.27M Buy
12,078
+1,819
+18% +$297K ﹤0.01% 1110
2020
Q3 		$1.32M Buy
10,259
+2,312
+29% +$255K ﹤0.01% 1284
2020
Q2 		$692K Sell
7,947
-1,087
-12% -$83.6K ﹤0.01% 1627
2020
Q1 		$545K Buy
9,034
+104
+1% +$7.7K ﹤0.01% 1555
2019
Q4 		$663K Sell
8,930
-10
-0.1% -$643 ﹤0.01% 1659
2019
Q3 		$546K Sell
8,940
-49,382
-85% -$3.25M ﹤0.01% 1731
2019
Q2 		$3.54M Buy
+58,322
New +$3.14M ﹤0.01% 1080

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cliff Asness's INSP Position: Q2 2026 in Review

Cliff Asness increased its Inspire Medical Systems (INSP) stake by 502% in Q2 2026, buying an estimated $73.4M and bringing the position to 1,856,800 shares worth $80.9M. The position accounts for 0.03% of the portfolio, ranked #669.

Cliff Asness first reported a position in INSP in Q2 2019 and has held it in 29 quarters since. The position peaked at $93.4M in Q3 2024. 274 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Cliff Asness held 1,856,800 shares of Inspire Medical Systems worth $80.9M as of Q2 2026.
  • Cliff Asness bought 1,548,138 Inspire Medical Systems shares in Q2 2026, an estimated $73.4M.
  • Inspire Medical Systems made up 0.03% of Cliff Asness's portfolio in Q2 2026, its #669 holding.
  • Cliff Asness first reported a position in Inspire Medical Systems in Q2 2019 and has held it in 29 quarters since.
  • Cliff Asness's Inspire Medical Systems position peaked at $93.4M in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.